Sign in

CIK 0001781983

  • Non-accelerated filer
  • Smaller reporting company

Aprea Therapeutics, Inc.

Sign in to watch
Ticker
APRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 215-948-4119
Business address
3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-10 Abrahmsen Lars B. SVP, Chief Scientific Officer Grant or award +24,700 43,700
2022-03-10 Abrahmsen Lars B. SVP, Chief Scientific Officer Grant or award · Stock Option (right to Buy) +100,000 100,000
2021-10-01 Abrahmsen Lars B. SVP, Chief Scientific Officer Exercise or conversion +50,000 $0.92 $46K 69,000
2021-10-01 Abrahmsen Lars B. SVP, Chief Scientific Officer Sale −50,000 $4.89 $245K 19,000
2021-10-01 Abrahmsen Lars B. SVP, Chief Scientific Officer Exercise or conversion · Stock Option (right to Buy) −50,000 30,587
2021-09-20 Abrahmsen Lars B. SVP, Chief Scientific Officer Exercise or conversion +25,000 $0.92 $23K 44,000
2021-09-20 Abrahmsen Lars B. SVP, Chief Scientific Officer Sale −25,000 $4.97 $124K 19,000
2021-09-20 Abrahmsen Lars B. SVP, Chief Scientific Officer Exercise or conversion · Stock Option (right to Buy) −25,000 80,587
2021-02-25 Abrahmsen Lars B. SVP, Chief Scientific Officer Grant or award +19,000 19,000
2021-02-25 Abrahmsen Lars B. SVP, Chief Scientific Officer Grant or award · Stock Option (right to Buy) +82,000 82,000
2020-03-24 Abrahmsen Lars B. SVP, Chief Scientific Officer Grant or award · Stock Option (right to Buy) +31,600 31,600
2019-10-07 Abrahmsen Lars B. SVP, Chief Scientific Officer Grant or award · Stock Option (right to Buy) +77,630 77,630

Page 1 of 1 · 12 trades